Could a Light-Activated cream replace surgery for cervical precancer?
NCT ID NCT07669363
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests a new approach for treating high-grade cervical precancer (HSIL) using a cream called HAL that is activated by a special light, instead of standard surgery. About 230 women will be randomly assigned to receive either the light therapy or surgery. The main goal is to see if the cream can clear the abnormal cells as effectively as surgery, while possibly being gentler and preserving fertility.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
hexaminolevulinate hydrochloride (HAL) 5% ointment with light therapy
What this could lead to
If successful, this could offer a non-surgical, outpatient option for treating cervical precancer, potentially preserving fertility and reducing recovery time.
What could go wrong
This is an early Phase II trial with only 230 participants, so results may not apply broadly. The treatment may not be as effective as surgery, and there is a small risk of progression to cancer if it fails.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLOMAVIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.